Compound Profiles
CJC-1295 (without DAC)
Short-Acting Growth Hormone Releasing Hormone Analog
Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.
GHRP-2
Growth Hormone Releasing Peptide-2 | Pralmorelin
GHRP-2 acts as a synthetic agonist of ghrelin, binding to the growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary. This stimulates cAMP production and promotes pulsatile release of endogenous growth hormone without suppressing natural feedback loops.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take CJC-1295 (without DAC) with GHRP-2?
Yes, CJC-1295 (without DAC) and GHRP-2 can generally be taken together. Potent combination maximizing GH through dual pathways.
Is CJC-1295 (without DAC) and GHRP-2 safe together?
Based on documented research, this combination is considered synergistic. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.
What are the interactions between CJC-1295 (without DAC) and GHRP-2?
Potent combination maximizing GH through dual pathways. This assessment has 95% confidence and is based on documented research data.
How should I time CJC-1295 (without DAC) and GHRP-2?
CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and GHRP-2 has a half-life of ~30 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.